China Universal Asset Management Company’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

China Universal Asset Management Company’s Portfolio RETA Stock Details RETA Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell
2023 Q2	$44.1K	Sell
2023 Q1	$39.5K	Buy
2022 Q4	$12.3K	Buy
2022 Q3	$7K	Buy